[ET Net News Agency, 16 January 2024] HANSOH PHARMA (03692) rose 3% to HK$13.7,
breaking above the 250-D SMA of HK$13.352.
It hits an intra-day high of HK$13.7, and an intra-day low of HK$13.14. The total shares
traded was 431,988, with a value of HK$5.85m. The active buy/sell ratio is 43:57, with net
selling turnover of HK$700,960. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$879,375, with volume weighted average price of HK$13.564.
DAIWA CAPITAL MARKETS HK accounts for greatest net responsive selling turnover of
HK$625,360, with volume weighted average price of HK$13.595.
The Hang Seng Index now fell 38 points, or 0.2% to 16,177.
Basic Information
=================
----------------------------------
Nominal 13.700 % Chg +3.01%
High 13.700 Low 13.140
Shares Tr 431,988 Turnover 5.85m
10-D SMA 13.908 %H.V 64.778
20-D SMA 14.369 VWAP 13.545
50-D SMA 14.644 RSI14 44.452
----------------------------------
Status: Breaking above the 250-D SMA, active buy/sell ratio is 43:57, with net selling
turnover of HK$700,960
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 13.70 +3.01
ALI HEALTH (00241) 3.65 -0.54
TRAD CHI MED (00570) 3.25 -0.91
CSPC PHARMA (01093) 6.27 -1.26
SINOPHARM (01099) 20.45 -0.73
SINO BIOPHARM (01177) 3.10 -0.64
CHINARES PHARMA (03320) 5.22 Unchanged
SCICLONE PHARMA (06600) 12.44 -2.05
JD HEALTH (06618) 31.65 -1.56
GOLDEN THROAT (06896) 3.47 +1.46
-----------------------------------------------
(ed)